Effects of direct thrombin or factor Xa inhibition on clot thrombogenicity in vitro: comparison of dabigatran with rivaroxaban and apixaban

被引：0
|
作者：
van Ryn, J. [1 ]
Kink-Eiband, M. [1 ]
Kuritsch, I [1 ]
Wienen, W. [2 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Drug Discovery Support, Biberach, Germany
[2] Boehringer Ingelheim GmbH & Co KG, Pulm Res, Biberach, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-181
引用
收藏
页码：687 / 688
页数：2
相关论文
共 50 条
  • [21] EFFECTS OF DABIGATRAN, A DIRECT THROMBIN INHIBITOR, AS COMPARED TO ENOXAPARIN AND THE DIRECT FACTOR XA INHIBITOR, RIVAROXABAN, ON TISSUE FACTOR-INDUCED PLATELET AGGREGATION IN HUMAN PLATELET RICH PLASMA
    van Ryn, J.
    Kink-Eiband, M.
    Hauel, N.
    Priepke, H.
    Wienen, W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 148 - 149
  • [22] Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombin
    Wong, Pancras C.
    Jiang, Xiaosui
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (02) : 302 - 310
  • [23] In-vitro inhibition of thrombin generation in heparin induced thrombocytopenia by dabigatran and rivaroxaban
    Gregor, H.
    Alena, S.
    Thomas, T.
    Greinacher, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 675 - 675
  • [24] Tissue factor-induced hypercoagulability in rats is increased by low doses of the direct thrombin inhibitor dabigatran but decreased by the factor Xa inhibitor rivaroxaban
    Perzborn, E.
    Heitmeier, S.
    Buetehorn, U.
    Volker, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 417 - 418
  • [25] Novel anticoagulants based an direct inhibition of thrombin and factor Xa
    Gardell, SJ
    Sanderson, PEJ
    CORONARY ARTERY DISEASE, 1998, 9 (2-3) : 75 - 81
  • [26] The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples
    Bonar, Roslyn
    Favaloro, Emmanuel J.
    Mohammed, Soma
    Ahuja, Monica
    Pasalic, Leonardo
    Sioufi, John
    Marsden, Katherine
    PATHOLOGY, 2016, 48 (01) : 60 - 71
  • [27] Prolongation of clot lysis time by a direct thrombin inhibitor melagatran mediated by paradoxical enhancement of thrombin generation: comparison with a direct factor Xa inhibitor edoxaban
    Morishima, Yoshiyuki
    Kamisato, Chikako
    Honda, Yuko
    BLOOD COAGULATION & FIBRINOLYSIS, 2021, 32 (03) : 209 - 215
  • [28] Effects of the oral, direct factor Xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity
    Graff, Jochen
    von Hentig, Nils
    Misselwitz, Frank
    Kubitza, Dagmar
    Becka, Michael
    Breddin, Hans-Klaus
    Harder, Sebastian
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (11): : 1398 - 1407
  • [29] Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay
    Artang, Ramin
    Anderson, Maren
    Riley, Paul
    Nielsen, Jorn D.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2017, 1 (02) : 194 - 201
  • [30] IN VITRO ASSESSMENT OF THE EFFECT OF DIRECT FACTOR XA INHIBITORS, APIXABAN AND RIVAROXABAN, ON INR MEASUREMENT IN BLOOD FROM WARFARIN-TREATED SUBJECTS
    Wang, Zhaoqing
    Knabb, Robert
    Frost, Charles
    Connolly, Thomas
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E76 - E76
12345